Although GBM with a mutant IDH gene (GBM, IDH-mutant) have a better prognosis than high grade gliomas with wildtype IDH [35], the strong correlation between IDH1 mutational status and the invasive characteristics was observed based on MRI (magnetic resonance imaging) studies [36]. This evidence concerns the gene IDH1 and central nervous system cancer.